B cell receptor dependent enhancement of dengue virus infection
Chad Gebo,Céline S. C. Hardy,Benjamin D. McElvany,Nancy R. Graham,Joseph Q. Lu,Shima Moradpour,Jeffrey R. Currier,Heather Friberg,Gregory D. Gromowski,Stephen J. Thomas,Gary C. Chan,Sean A. Diehl,Adam T. Waickman
DOI: https://doi.org/10.1371/journal.ppat.1012683
IF: 7.464
2024-11-01
PLoS Pathogens
Abstract:Dengue virus (DENV) is the causative agent of dengue, a mosquito-borne disease that represents a significant and growing public health burden around the world. A unique pathophysiological feature of dengue is immune-mediated enhancement, wherein preexisting immunity elicited by a primary infection can enhance the severity of a subsequent infection by a heterologous DENV serotype. A leading mechanistic explanation for this phenomenon is antibody dependent enhancement (ADE), where sub-neutralizing concentrations of DENV-specific IgG antibodies facilitate entry of DENV into FcγR expressing cells such as monocytes, macrophages, and dendritic cells. Accordingly, this model posits that phagocytic mononuclear cells are the primary reservoir of DENV. However, analysis of samples from individuals experiencing acute DENV infection reveals that B cells are the largest reservoir of infected circulating cells, representing a disconnect in our understanding of immune-mediated DENV tropism. In this study, we demonstrate that the expression of a DENV-specific B cell receptor (BCR) renders cells highly susceptible to DENV infection, with the infection-enhancing activity of the membrane-restricted BCR correlating with the ADE potential of the IgG version of the antibody. In addition, we observed that the frequency of DENV-infectible B cells increases in previously flavivirus-naïve volunteers after a primary DENV infection. These findings suggest that BCR-dependent infection of B cells is a novel mechanism immune-mediated enhancement of DENV-infection. Dengue virus (DENV) is a mosquito-borne pathogen that infects an estimate 400 million people every year. A unique feature of DENV is immune-mediated enhancement, wherein a first (primary) DENV infection can predispose an individual to a more severe secondary infection. The leading explanation for this phenomenon is antibody dependent enhancement (ADE), wherein antibodies generated in response to a primary DENV infection bind but fail to neutralize virions introduced during a secondary infection, thereby allowing DENV to gain entry to Fc-receptor expressing cells. Accordingly, a key prediction of this model is that monocytes, macrophages, and other Fc-receptor expressing phagocytes should be the primary cellular reservoir of DENV during an acute secondary DENV infection. However, it has been noted for decades that B cells are a significant cellular reservoir of DENV, including during secondary DENV infection, representing a disconnect in our understanding of immune-mediated DENV tropism. In our study, we identified DENV-reactive B cell receptors (BCR) as a potent DENV entry receptor. This observation suggests that BCR-dependent infection of DENV-specific B cells may be a complementary mechanism of immune-mediated enhancement of DENV-infection that expands upon and complements existing models of antibody-dependent enhancement.
microbiology,virology,parasitology